SWITCH OF INFLIXIMAB ORIGINATOR TO BIOSIMILAR CT-P13 IN PATIENTS WITH CROHN´S DISEASE AND ULCERATIVE COLITIS IN A LARGE GERMAN IBD CENTER. A ONE YEAR, RANDOMIZED AND PROSPECTIVE TRIAL

Helene Röder  1     Fabian Schnitzler  2     Jens Borchardt  3     Shorena Janelidze  4     Thomas Ochsenkühn  5    
1 Ludwig Maximilian's University Munich Medical Center,Munich,Germany
2 Helios Amper-Klinikum Dachau,Dachau,Germany
3 Onkotrakt AG,Hamburg,Germany
4 Synesis Research Center,Munich,Germany
5 Isarklinikum,Munich,Germany

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing